-
biomolecular condensates of the PSD, as a novel approached to tackle neurological disorders. Supervisor: Professor Kristian Strømgaard, Department of Drug Design and Pharmacology. Start September 1st, 2025
-
. Below, intended research objectives are listed, but the list is not exclusive. We expect the qualified candidate to further define the plan for the PhD within the first three months of employment
-
2) and ensures a smooth transition to partners for later stages of development. By connecting science, innovation, clinical trials, regulatory processes, and product development, NIVI aims
-
: albert.schliesser@nbi.ku.dk , phone: +4535325401) If it is deemed appropriate from an overall perspective, you must be prepared to be security screened, in relation to international research and innovation